Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy
Status:
Withdrawn
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
People with epilepsy often experience problems with their memories and other thinking skills
that get worse over time. The investigators hope to learn more about whether a drug called
memantine can help improve or stabilize (keep the same) memory and other thought processes in
people with epilepsy by blocking a chemical that is released in the brain during seizures.
The investigators also want to see if memantine changes the frequency (how often) people with
epilepsy have seizures. Memantine is currently approved by the United States Food and Drug
Administration (FDA) for treatment of patients with Alzheimer's disease.
Phase:
N/A
Details
Lead Sponsor:
Michael A. Rogawski, MD, PhD University of California, Davis